ibandronic acid has been researched along with Bone Diseases in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida Paz, FA; Barbosa, JS; Braga, SS | 1 |
| Alegre, A; Bailén, A; Giraldo, P; Gironella, M | 1 |
| Criscitiello, C; Curigliano, G; De Laurentiis, M; De Placido, S; Esposito, A; Gelao, L; Goldhirsch, A; Santangelo, M; Viale, G | 1 |
| Curtis, D; Lu, Y; Qiao, D; Wang, Z; Wen, X; Yao, Y; Zhao, H | 1 |
| Brown, JE; Coleman, RE; Dodwell, D; Ellis, SP; Gutcher, SA; Hannon, RA; Horsman, JM; Lester, JE; Purohit, OP; Thorpe, R | 1 |
| Pecherstorfer, M | 1 |
| Lipton, A | 1 |
| Christopoulos, C; Kalogeropoulou, C; Kardamakis, D; Leotsinides, M; Solomou, E; Vassiliou, V | 1 |
| Athavale, S; Aya-ay, J; Bauss, F; Bian, H; Kim, HK; Morgan-Bagley, S | 1 |
| Clemons, M; Cole, DE; Dranitsaris, G; Ooi, W | 1 |
| Bergner, R; Henrich, DM; Hoffmann, M; Honecker, A; Mikus, G; Nagel, D; Nauth, B; Uppenkamp, M | 1 |
| Jones, G; Winzenberg, T | 1 |
| Alsina, M; Anderson, JL; Craig, F; Cruz, JC; Dallas, M; Roodman, GD; Yoneda, T | 1 |
7 review(s) available for ibandronic acid and Bone Diseases
| Article | Year |
|---|---|
Bisphosphonates, Old Friends of Bones and New Trends in Clinics.
Topics: Animals; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Drug Compounding; Drug Delivery Systems; Humans | 2021 |
Zoledronic acid in the management of bone disease as a consequence of multiple myeloma: a review.
Topics: Antineoplastic Agents; Bone Diseases; Clodronic Acid; Diphosphonates; Drug Monitoring; Humans; Ibandronic Acid; Imidazoles; Multiple Myeloma; Pamidronate; Zoledronic Acid | 2014 |
Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Bone Remodeling; Bone Resorption; Clodronic Acid; Denosumab; Diphosphonates; Humans; Ibandronic Acid; Imidazoles; Immune System; Osteoclasts; Osteoprotegerin; Pamidronate; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Signal Transduction; Treatment Outcome; Zoledronic Acid | 2015 |
Systematic literature review and network meta-analysis comparing bone-targeted agents for the prevention of skeletal-related events in cancer patients with bone metastasis.
Topics: Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Denosumab; Diphosphonates; Humans; Ibandronic Acid; Imidazoles; Neoplasms; Pamidronate; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid | 2015 |
Efficacy and safety of ibandronate in the treatment of neoplastic bone disease.
Topics: Bone Diseases; Bone Neoplasms; Bone Remodeling; Bone Resorption; Diphosphonates; Female; Humans; Ibandronic Acid; Male | 2004 |
New therapeutic agents for the treatment of bone diseases.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Diseases; Bone Diseases, Metabolic; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Imidazoles; Pamidronate; Randomized Controlled Trials as Topic; Zoledronic Acid | 2005 |
Ibandronate in benign bone disease.
Topics: Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Humans; Ibandronic Acid | 2008 |
3 trial(s) available for ibandronic acid and Bone Diseases
| Article | Year |
|---|---|
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer.
Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Bone Density; Bone Density Conservation Agents; Bone Diseases; Breast Neoplasms; Diphosphonates; Double-Blind Method; Female; Fractures, Bone; Humans; Ibandronic Acid; Lumbar Vertebrae; Middle Aged; Nitriles; Placebos; Triazoles | 2008 |
A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Middle Aged; Pain; Palliative Care; Pamidronate | 2008 |
Renal safety and pharmacokinetics of ibandronate in multiple myeloma patients with or without impaired renal function.
Topics: Adult; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Renal Insufficiency | 2007 |
3 other study(ies) available for ibandronic acid and Bone Diseases
| Article | Year |
|---|---|
Combination ibandronate and radiotherapy for the treatment of bone metastases: clinical evaluation and radiologic assessment.
Topics: Aged; Analgesics, Opioid; Bone Density Conservation Agents; Bone Diseases; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Female; Humans; Ibandronic Acid; Infusions, Intravenous; Magnetic Resonance Imaging; Male; Middle Aged; Pain; Pain Measurement; Pilot Projects; Prospective Studies; Statistics, Nonparametric | 2007 |
Retention, distribution, and effects of intraosseously administered ibandronate in the infarcted femoral head.
Topics: Animals; Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Disease Models, Animal; Femur; Ibandronic Acid; Infarction; Swine | 2007 |
Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
Topics: Animals; Bone Diseases; Bone Marrow Cells; Cell Division; Cell Survival; Diphosphonates; Disease Models, Animal; Humans; Hypercalcemia; Ibandronic Acid; Immunoglobulin G; Immunoglobulin kappa-Chains; Leukemia, Plasma Cell; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Osteoclasts; Osteolysis; Paraplegia; Tumor Cells, Cultured | 2001 |